TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Sickle Cell Disease Market is Predicted to Exhibit Remarkable Growth at a CAGR of 22.1% During the Forecast Period (2025–2034) Across 6MM, Owing to the Increasing Prevalence, Awareness, and Advancements in Gene Therapies | DelveInsight

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Delveinsight
Sickle Cell Disease Market is Predicted to Exhibit Remarkable Growth at a CAGR of 22.1% During the Forecast Period (2025–2034) Across 6MM, Owing to the Increasing Prevalence, Awareness, and Advancements in Gene Therapies | DelveInsight

The sickle cell disease market is projected to grow at a 22.1% CAGR by 2034, driven by increasing disease prevalence, awareness, and advancements in gene therapies, with emerging treatments from multiple pharmaceutical companies.

Insights
CHACU   neutral

Involved in a potential business combination with Xanadu, providing potential funding but no specific technological achievements mentioned


PFE   positive

Developing multiple promising therapies like inclacumab, osivelotor, actively participating in SCD treatment innovation